N/A
Manufactured by Novo Nordisk
154,936 FDA adverse event reports analyzed
Last updated: 2026-05-19
Ozempic is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Novo Nordisk. The most commonly reported adverse reactions for Ozempic include NAUSEA, VOMITING, OFF LABEL USE, DIARRHOEA, CONSTIPATION. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for Ozempic.
Out of 76,469 classified reports for Ozempic:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 154,936 FDA FAERS reports that mention Ozempic. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include NAUSEA, VOMITING, OFF LABEL USE, DIARRHOEA, CONSTIPATION, DECREASED APPETITE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Novo Nordisk in connection with Ozempic. Always verify the specific product and NDC with your pharmacist.
Explore other medications manufactured by Novo Nordisk and compare their safety profiles:
The following drugs share commonly reported adverse reactions with Ozempic: